Literature DB >> 6325917

Transmission of the polyoma virus middle T gene as the oncogene of a murine retrovirus.

D J Donoghue, C Anderson, T Hunter, P L Kaplan.   

Abstract

Polyoma virus is a papovavirus that productively infects mouse cells. In cells of other species, such as rat cells, polyoma virus is virtually unable to replicate, and a small proportion of infected cells become stably transformed. The ability of polyoma virus to transform infected cells is determined by genes that encode the large, middle and small T antigens and which are found in the early region of the virus genome. We have inserted the transforming region of polyoma virus into a murine leukaemia virus (MLV) vector, to generate a replication-defective transforming retrovirus which for the first time allows efficient transformation of mouse cells by the polyoma virus middle T gene. During the life cycle of this recombinant virus the intervening sequence present in the original polyoma virus middle T gene was removed. The recombinant virus that we have constructed is analogous to other acutely transforming retroviruses, and demonstrates that the polyoma middle T gene is a dominant transforming oncogene.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325917     DOI: 10.1038/308748a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  29 in total

1.  Raf-1 protein kinase is an integral component of the oncogenic signal cascade shared by epidermal growth factor and platelet-derived growth factor.

Authors:  S Kizaka-Kondoh; K Sato; K Tamura; H Nojima; H Okayama
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

2.  Progression of the phenotype of transformed cells after growth stimulation of cells by a human papillomavirus type 16 gene function.

Authors:  T Noda; H Yajima; Y Ito
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

3.  A retrovirus carrying the polyomavirus middle T gene induces acute thrombocythemic myeloproliferative disease in mice.

Authors:  A Fusco; G Portella; M Grieco; G Tajana; G Di Minno; N Polli; A Pinto
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

4.  Altered sites of tyrosine phosphorylation in pp60c-src associated with polyomavirus middle tumor antigen.

Authors:  C A Cartwright; P L Kaplan; J A Cooper; T Hunter; W Eckhart
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

5.  Dephosphorylation or antibody binding to the carboxy terminus stimulates pp60c-src.

Authors:  J A Cooper; C S King
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

6.  A completely transformation-defective point mutant of polyomavirus middle T antigen which retains full associated phosphatidylinositol kinase activity.

Authors:  B J Druker; L E Ling; B Cohen; T M Roberts; B S Schaffhausen
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

7.  Recombinant retroviruses that transduce middle T antigen cDNAs derived from polyomavirus mutants: separation of focus formation and soft-agar growth in transformation assays and correlations with kinase activities in vitro.

Authors:  W C Morgan; D R Kaplan; D C Pallas; T M Roberts
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

8.  Temperature-sensitive cellular mutant for expression of mRNA from murine retrovirus.

Authors:  H Inoue; S Kizaka; M Yutsudo; A Hakura
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

9.  Mutation of a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and phosphatidylinositol-3 kinase, activation of c-fos expression, and cellular transformation.

Authors:  G M Glenn; W Eckhart
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

10.  High mutation rate of a spleen necrosis virus-based retrovirus vector.

Authors:  J P Dougherty; H M Temin
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.